亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)唑來膦酸Zoledronic acid

 
 
單價 8500.00 / 公斤對比
銷量 暫無
發(fā)貨 陜西西安市付款后3天內(nèi)
庫存 1000公斤起訂1公斤
品牌 博萌生物
型號 045
規(guī)格 98%
過期 長期有效
更新 2020-07-14 15:47
 

Xi’an Spring-chem Bio-tech Co. Ltd

企業(yè)會員第13年
資料未認(rèn)證
保證金未繳納
  • 陜西-西安市
  • 上次登錄 2020-07-14
  • 杜先生 (先生)   經(jīng)理
詳細(xì)說明

唑來膦酸Zoledronic acid
中文名:唑來膦酸
英文名:Zoledronic acid
化學(xué)名:1-羥基-2-(咪唑-1-yl)-亞乙基-1,1-二磷酸一水化物。
分子式: C5H10N2O7P2
分子量: 272.09
CAS No.: 118072-93-8
含量: 99%
特性: 白色或淡黃色結(jié)晶粉末,無臭, 易溶于水。
熔點237239
包裝:雙層塑料袋加鋁箔袋(1公斤/包)
儲藏條件:陰涼、干燥、避光。
有效期:24個月。
主要功效及作用:適用于惡性腫瘤引起的高鈣血癥、溶骨性骨轉(zhuǎn)移引起的骨痛、骨質(zhì)疏松癥等。
舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
現(xiàn)貨供應(yīng)芒果甙Mangiferin 現(xiàn)貨供應(yīng)芹菜素Apigenin 現(xiàn)貨供應(yīng)虎杖甙Polydatin 現(xiàn)貨供應(yīng)左旋肉堿(L-肉堿) 現(xiàn)貨供應(yīng)木犀草素luteolin 現(xiàn)貨供應(yīng)蒼耳子/蒼術(shù)/側(cè)柏葉提取物 供應(yīng)天麻提取物/洋金花提取物
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |